Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma.
Bauduer
F
F
D000368:Aged; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007952:Leukemia, Plasma Cell / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000601:surgery; D013792:Thalidomide / Q000627:therapeutic use*; D014182:Transplantation, Autologous
D007166:Immunosuppressive Agents; D013792:Thalidomide